Followers | 17 |
Posts | 1957 |
Boards Moderated | 1 |
Alias Born | 09/27/2020 |
Monday, December 11, 2023 3:19:33 PM
But that's exactly what Pfizer did with the earlier work of Dr. Arad and that was incorporated into Paxlovid. Pax has stronger 3CL protease inhibition characteristics than Tollovid, but Tollovid is more than capable of doing the job and doesn't have the issues of Paxlovid with continued use. There's tons of documented cases where severe rebound in Covid and Long Covid after Paxlovid use is discontinued. Tollovid doesn't have that issue because it can be used without side effects or harm until the immune system can return to normal.
Recent TOMDF News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 07/17/2023 12:29:32 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM